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Abstract 
Background: In recent years the emergence of multidrug resistant Klebsiella pneumoniae strains has been an increas‑
ingly common event. This opportunistic species is one of the five main bacterial pathogens that cause hospital infec‑
tions worldwide and multidrug resistance has been associated with the presence of high molecular weight plasmids. 
Plasmids are generally acquired through horizontal transfer and therefore is possible that systems that prevent the 
entry of foreign genetic material are inactive or absent. One of these systems is CRISPR/Cas. However, little is known 
regarding the clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/
Cas) system in K. pneumoniae. The adaptive immune system CRISPR/Cas has been shown to limit the entry of foreign 
genetic elements into bacterial organisms and in some bacteria it has been shown to be involved in regulation of 
virulence genes. Thus in this work we used bioinformatics tools to determine the presence or absence of CRISPR/Cas 
systems in available K. pneumoniae genomes.
Results: The complete CRISPR/Cas system was identified in two out of the eight complete K. pneumoniae genomes 
sequences and in four out of the 44 available draft genomes sequences. The cas genes in these strains comprises 
eight cas genes similar to those found in Escherichia coli, suggesting they belong to the type I‑E group, although their 
arrangement is slightly different. As for the CRISPR sequences, the average lengths of the direct repeats and spac‑
ers were 29 and 33 bp, respectively. BLAST searches demonstrated that 38 of the 116 spacer sequences (33%) are 
significantly similar to either plasmid, phage or genome sequences, while the remaining 78 sequences (67%) showed 
no significant similarity to other sequences. The region where the CRISPR/Cas systems were located is the same in all 
the Klebsiella genomes containing it, it has a syntenic architecture, and is located among genes encoding for proteins 
likely involved in metabolism and resistance to antibiotics.
Conclusions: The CRISPR/Cas system is not widely distributed in K. pneumoniae genomes, those present most likely 
belong to type I‑E with few differences from the arrangement of the cse3 gene and most of the spacers have not 
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been are not described yet. Given that the CRISPR/Cas system is scarcely distributed among K. pneumoniae genomes 
it is not clear whether it is involved in either immunity against foreign genetic material or virulence. We consider that 
this study represents a first step to understand the role of CRISPR/Cas in K. pneumoniae.
Keywords: CRISPR/Cas, Bacterial immune system, Bacteriophages, Plasmids, Multiple drug resistance
the exchange of genetic material and they may affect its 
evolution rate [8]. Additionally, the CRISPR/Cas expres-
sion is tightly regulated but the information is limited to 
some genera [3, 5, 8–13].
Furthermore, an additional function has recently been 
attributed to this system: That is regulation of gene 
expression related to virulence. This function has been 
observed in several pathogenic bacteria [8, 14, 15]. Some 
studies highlight the potential of the CRISPR/Cas system 
to modulate bacterial physiology and the unexpected 
forms that could mitigate or increase its virulence [14]. 
In this regard, in Pseudomonas aeruginosa this system is 
capable of modulating biofilm production, an important 
virulence factor for this and various other pathogenic 
microorganisms [15]; in Streptococcus pyogenes the pres-
ence of the CRISPR/Cas system modulates prophage 
contents and hence its virulence; in Enterococcus faeca-
lis and E. faecium a correlation between the absence of 
CRISPR/Cas and the presence of antimicrobial resistance 
genes has been determined [14–16]. Lastly, in Francisella, 
RNA-RNA interactions (mediated by the Cas9 protein), 
result in a reduction of essential lipoprotein transcripts 
for the pro-inflammatory response of the host, conse-
quently these bacteria persist and cause infection in ani-
mal models [14, 15]. For these reasons, the role of this 
system in modulating virulence and antibiotic resistance 
in different bacterial pathogens represents an excellent 
opportunity as a research area.
Klebsiella pneumoniae is among the bacteria that have 
emerged as important opportunistic pathogens in hos-
pital environments due to their high rate of antibiotic 
resistance and high degree of dispersion [17, 18]. The 
multidrug resistance of this bacterium has been associ-
ated with the presence of high molecular weight plasmids 
[17, 19]. Despite the increasing information on the pres-
ence of CRISPR/Cas in several pathogens, information 
about these systems in K. pneumoniae is scarce. There-
fore, the main goal of this study was to determine, by 
means of bioinformatics tools and manual curation, the 
presence or absence of the CRISPR/Cas system in avail-
able K. pneumoniae genomes. Our results show that 
the CRISPR/Cas system is not homogeneously distrib-
uted in these bacteria and in those where it is present it 
is inserted at the same genome site. Additionally, most 
DR sequences in the CRISPR elements are specific for K. 
pneumoniae, as no homologues were found.
Background
During bacterial evolution, the ability of bacteria to 
adapt to new environments has been favored by the 
acquisition of genes through horizontal gene transfer 
(HGT) [1]. Despite this apparent advantage, each organ-
ism must balance the need to acquire beneficial charac-
teristics through HGT with the need to prevent the entry 
of genetic elements that impose additional energy costs. 
A system that allows bacteria to limit the entry of genetic 
elements is the adaptive immune system CRISPR/
Cas (clustered regularly interspaced short palindromic 
repeats and their associated Cas proteins), which has 
been described in many Bacteria and Archaea. Extensive 
research has shown that when a microorganism contains 
the CRISPR/Cas system in its genome, it survives initial 
infection by phages or plasmids because it can acquire 
a short DNA fragment, and then start up its machinery 
to recognize and degrade them. When the incoming 
DNA is harmful to the cell, e.g. lytic phages, having an 
active CRISPR/Cas system offers a selective advantage. 
In contrast, when external DNA is required for survival, 
e.g. against antibiotic-selective conditions, this inhibi-
tion can be detrimental [2, 3]. This prokaryotic immune 
system is based on the use of small RNAs that limit 
phage infection and the entrance of plasmids [2, 3]. The 
CRISPR elements are composed of small direct repeat 
sequences (DR) between 21 and 48 base pairs (bp), sepa-
rated by hypervariable sequences or spacers that range 
in size from 26 to 72  bp. Many of these sequences are 
derived from mobile genetic elements such as plasmids 
and phages [2, 4, 5]. An important step in understand-
ing the role of CRISPR was the identification of genes 
located very close to them and their conservation in the 
different CRISPR systems. These genes were called cas 
because of their association with the CRISPR repeats 
[4, 6]. It was determined that the Cas proteins contain 
domains characteristic of nucleases, helicases, polymer-
ases and various RNA-binding proteins [7]. The number 
of cas genes may vary from 4 to over 20 and the prod-
uct of these genes, the Cas proteins, provide the enzy-
matic machinery required for the acquisition of spacers 
as well as for invader element marking. The central Cas 
proteins are characterized by their proximity to the 
CRISPR loci and are widely distributed among bacterial 
and archaeal species. Experiments in multiple bacteria 
have shown that these systems play an important role in 
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Results
Survey of CRISPR/Cas system in K. pneumoniae genomes
Given that only a small number of K. pneumoniae 
genomes have been completely annotated and reported 
we used also completed but not assembled genomes in 
this study. In total, 52 complete and draft genomes of 
K. pneumoniae were analyzed for the presence of com-
ponents of the CRISPR/Cas system by using the CRIS-
PRFinder software [20]. This program was used with the 
genomes already loaded on its database and with draft 
sequences that were uploaded manually after BLAST 
searches were performed as described in the "Methods" 
section. CRISPR sequence arrays and cas genes were 
detected in two out of the eight complete genomes and 
in four out of the 44 draft genome sequences available 
(Table  1 and Additional file  1: Table S1). In some cases 
CRISPRFinder detected regions with CRISPR, such as 
strains 342 and JM45, but no adjacent cas genes were 
found. These sequences were not considered to have a 
CRISPR/Cas system and were not included in the sub-
sequent analysis. In order to corroborate CRISPRFinder 
results, five 20 kbp random sequences derived from the 
strain 1084 were generated (see "Methods" section) and 
analyzed. These data showed that no CRISPR sequences 
were found in any of the sequences analyzed. Taken 
together these results demonstrate that the CRISPR/Cas 
system is not homogenously distributed in all K. pneumo-
niae strains and it was found in only 12% of the analyzed 
strains.
Genomic context of CRISPR/Cas
In general, based on the MAUVE alignment (for details 
refer to "Methods" section) it was observed that the 
region where the cas operon is located in all genomes, 
only one locally collinear block (LCB) was found. There-
fore, this region seems to be shared and syntenic. In 
the genomes of the strains NTUH-K2044 [GenBank: 
NC_012731], WGLW2 [GenBank: NZ_JH930419], and 
WGLW5 [GenBank: NZ_JH930428], this system was 
found encoded in the complementary strand. In contrast, 
in the genomes of strains 1084 [GenBank: NC_018522], 
JHCK1 [GenBank: NZ_ANGH02000012] and RYC492 
[GenBank: NZ_APGM01000001], it was found encoded 
in the plus strand. We also found that upstream and 
downstream sequences of the cas operon were variable 
in all cases, which shows the variability of the CRISPR 
sequences (Fig. 1).
When analyzing the region upstream of the CRISPR/
Cas we observed that genes were identical and encode 
for different subunits of an ABC type transporter (ID: 
AFQ65464, AFQ65465, AFQ65466), multiple subunits of 
a formate dehydrogenase (ID: AFQ65461), malate dehy-
drogenase (ID: AFQ65462), and amino acid transporters 
(ID: AFQ65453, AFQ65454, AFQ65460). Interestingly, 
we also found genes that seem to code proteins for anti-
microbial resistance such as glyoxalase and efflux pumps 
(MdtM, multidrug efflux system protein) (ID: AFQ65457, 
AFQ65459, EMH97621). On the other hand, and similarly 
that observed at the 5′ end, at the 3′ end of the CRISPR/
Cas region there was no variability. This region contains 
genes related to antibiotic resistance, such as lactoylglu-
tathione lyase (or glyoxalase, which confers resistance to 
bleomycin) (ID: AFQ65478), and genes encoding different 
subunits of proteins involved in cell metabolism, such as 
2-gluconate dehydrogenase (ID: AFQ65479, AFQ65480, 
AFQ65481), heme protein exporters (ID: BAH63785, 
BAH63784), and proteins involved in the biogenesis of 
cytochrome C (ID: AFQ63377, AFQ63378, AFQ65482, 
AFQ65483, AFQ65484, AFQ65485, AFQ65486, 
AFQ65487, AFQ65488) (Fig.  2a). In the draft genomes, 
most of the genes are annotated as hypothetical; however, 
a detailed analysis of this region reveals that the size and 
sequence of the genes is similar amongst all genomes with 
these systems. Taken together our analysis demonstrated 
that those K. pneumoniae strains harboring a CRISPR/Cas 
system are syntenic.
Table 1 Klebsiella pneumoniae strains with a CRISPR/Cas system
NR no reference, WGLW2 and WGLW5 genomes were submitted by Broad Institute, BioProjects PRJNA181874, PRJNA169454 and PRJNA181876, PRJNA169456 
respectively, available in NCBI.
a CRISPR/Cas system was detected with the CRISPRFinder software.
Strain Origin Genome status Number of CRISPRa Number of spacersa GenBank access no. References
K. pneumoniae subsp. pneumoniae 
1084
Liver abscess Complete 2 8 and 14 NC_018522 [21, 22]
K. pneumoniae NTUH‑K2044 Liver abscess Complete 2 3 and 22 NC_012731 [23]
K. pneumoniae JHCK1 Meningitis Draft 2 9 and 15 NZ_ANGH02000012 [24, 25]
K. pneumoniae RYC492 Stool Draft 1 11 NZ_APGM01000001 [26, 27]
K. pneumoniae WGLW2 Sputum Draft 1 9 NZ_JH930419 NR
K. pneumoniae WGLW5 Mouse Draft 2 6 and 19 NZ_JH930428 NR
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Organization of the cas operon
As mentioned before, for the CRISPR/Cas systems 
there are always associated coding genes to the CRISPR 
sequences. K. pneumoniae, draft genomes and complete 
genomes, this system consists of eight cas genes that are 
syntenic (Fig. 2b). The cas genes identified were, from 5′ 
to 3′ direction: cas3, cse1 also known as casA, cse2 also 
known as casB, cse3 or casE, cse4 or casC, cas5e, cas1 
and cas2. As a whole, this suggests that the cas operon 
is conserved in those strains containing CRISPR/Cas 
systems and probably has a common evolutionary his-
tory in all these Klebsiella strains. This finding suggests 
that the cenancestor of Klebsiella contained the CRISPR 
system.
Analysis of the CRISPR sequences
In all genomes containing the CRISPR/Cas system, 
CRISPR sequences were found upstream of the cas3 
gene and downstream of the cas2 gene, in those genomes 
with two CRISPR arrays. Strains RYC492 and WGLW2, 
presented only one CRISPR array. In the RYC492 strain, 
the array was located downstream of cas2 and contained 
11spacers. In the WGLW2 genome the CRISPR sequence 
was upstream of cas3 and had 3 spacers (Table 1; Fig. 2). 
Strains NTUH-K2044, 1084 and JHCK1 had two CRISPR 
arrays: The NTUH-K2044 strain contained 22 spac-
ers in one array (downstream of cas2) and three in the 
upstream of cas3; strain 1084 presented 14 and 8 spacers 
(downstream of cas2 and upstream of cas3), respectively, 
whereas strain JHCK1 contained 15 and 9 spacers (down-
stream of cas2 and upstream of cas3). The average length 
of the repeats was 29 bp whereas spacers had an average 
length of 33 bp.
Subsequently, and based on the comparison of the cas 
operon of K. pneumoniae with that of E. coli (Type I-E or 
CASS2), we observed that K. pneumoniae strains have the 
same number of genes but with a difference in the loca-
tion of cse3. That is, for E. coli cse3 is located downstream 
of cas5e while in K. pneumoniae it is located between cse2 
and cse4 (Fig. 2). Whether this rearrangement influences 
the formation of the CASCADE complex involved in the 
recognition of foreign genetic material in K. pneumoniae 
Fig. 1 Location of CRISPR/Cas system in the genome of diverse strains of Klebsiella pneumoniae. Alignment generated with Progressive MAUVE of 
the six genomes that contain CRISPR/Cas. The region was grouped into a single locally collinear block (red). At the ends of the cas operon (empty or 
blank regions marked by yellow arrows), there is variability, probably due to the presence of CRISPR sequences.
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still unknown and a matter of future research. In order to 
characterize the DRs in each CRISPR sequence we per-
formed a detailed analysis by aligning all 10 of the DRs 
obtained through the analysis derived from the CRIS-
PRFinder. The consensus sequence of these DRs showed 
a conserved GT(C/g)TTCCCC sequence at the 5′ region 
and a conserved GGGG(G/a)T(G/a)(T/a) (T/a)(T/c)C 
at the 3′ region. The main changes were detected in the 
middle of the sequence (position 12 to 15). Our results 
show that the DR sequence was symmetrical and par-
tially palindromic (Fig. 3). Given the immune role exerted 
by the CRISPR/cas system, it has been observed that the 
spacer sequences are derived from HGT material [28]. In 
order to define the origin of the spacers in the systems 
identified in K. pneumoniae BLASTn searches were per-
formed. This analysis showed that 38 of the 116 spacer 
sequences (33%) have significant similarity to plasmids, 
phages or genome sequences in Klebsiella or other bac-
teria. The distribution of these sequences was: 13% 
(15/116) of the spacer sequences had similarity to genes 
belonging to phages, 8% (9/116) corresponded to gene 
sequences of plasmids, 5% (6/116) to genes of the Kleb-
siella spp. genome, while 7% (8/116) were similar to genes 
that belong to genomes of other bacteria. The remaining 
78 sequences (67%) showed no significant similarity to 
any other sequence (Fig. 3). In addition, strains that share 
spacer sequences were not detected. These results show 
a diverse origin of the CRISPR sequences, indicating that 
they were probably acquired from diverse events involv-
ing the entry of foreign genetic material.
Discussion
The CRISPR/Cas systems are involved in limiting the 
entrance of foreign DNA to Bacteria and Archaea and 
have also been related to the expression of virulence 
factors in Bacteria. These systems have been widely 
studied in several organisms including pathogens and 
non-pathogens but few studies have demonstrated their 
in  vivo activity [29]. Hence, and according to Bondy-
Denomy  and Davidson, 2014, the information on the 
content of spacers, the percentage of them presenting 
concordance with a known sequence or of those that 
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Fig. 2 Genomic context of the CRISPR/Cas system in diverse strains of Klebsiella pneumoniae. a Genomic context of cas operon. Enzymes related 
to bacterial metabolism and some antibiotic resistance genes are located in the vicinity of cas operon. b CRISPR/Cas organization. The cas operon 
consists of eight genes and the CRISPR sequences are located downstream from cas2 and upstream from cas3 in those genomes containing two 
CRISPR arrays.
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are unique to a specific species, is hard to find in publi-
cations, and would provide a fundamental point of view 
on the functionality of this system. These data will be 
useful to interpret the functions of these systems in the 
strains being studied and will improve our understand-
ing of bacterial evolution, as well as the impact of hori-
zontal transfer of genes in the environment and human 
health [29]. To our understanding these systems have 
not been studied yet or characterized in K. pneumoniae. 
K. pneumoniae is among the top five pathogens causing 
nosocomial infections worldwide and it belongs to the 
ESKAPE group [30–35]. K. pneumoniae easily disperses 
in hospital wards, contains diverse virulence factors and 
has large plasmids conferring ecological advantages for 
its adaptation to several niches [17, 18]. We were there-
fore interested in knowing whether K. pneumoniae 
has CRISPR/Cas systems and whether or not these are 
related to HGT, multidrug resistance (MDR) or viru-
lence. Here we used bioinformatics tools to determine 
the presence or absence of CRISPR/Cas systems in the 
available K. pneumoniae genomes. Our results revealed 
the presence of these systems in six out of 52 (8 com-
plete and 44 draft) genomes available in databases. The 
latter suggests that CRISPR/Cas systems are not widely 
distributed in this bacterial species. Given the MDR 
characteristics and plasmid presence for all the analyzed 
strains shown in Additional file 1: Table S1 it is not pos-
sible to conclude whether the CRISPR/Cas system is 
related to either drug resistance or presence or absence 
of plasmids. Given that CRISPR/Cas systems are poorly 
distributed amongst K. pneumoniae strains they are not 
useful as a typing method as in other bacterial species. 
Determining whether these systems are related to MDR 
or to the presence of plasmids or phages requires further 
experimentation.
In the strains where the CRISPR/Cas system was found, 
it is located at the same site in all the genomes. The loca-
tion of CRISPR/Cas systems is quite variable in other 
bacteria that have them for example in Gardnerella vagi-
nalis it is located between clpC and the gene encoding 
for tRNAGly [36]; in Campylobacter jejuni (strain UPTC 
CF89-12) and Campylobacter lari (strain RM2100), the 
system is found between the tmrU structural genes and a 
PGPase [37]. In E. coli K12 and S. Typhimurium LT2, the 
system is found among metabolic genes. In our study we 
observed that in K. pneumoniae the system was located 
downstream from genes possibly encoding for subunits 
of an ABC transporter and upstream of a possible hemag-
glutinin. Based on our results and those described before 
it appears that the location of the CRISPR/Cas system 
Fig. 3 Description of direct repeats and spacer sequences found in Klebsiella pneumoniae genomes. a Logo obtained in WebLogo of the direct 
repeats consensus sequences of CRISPR arrays. The sequences are partially palindromic and symmetrical. b Match of spacer sequences with 
sequences of phages, plasmids and bacterial genomes deposited in GenBank.
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differs depending on the bacteria, while it seems to be 
located at the same site in the genome among strains of 
the same species.
We also searched for cas genes closely related to the 
CRISPR arrays in those K. pneumoniae genomes con-
taining the CRISPR/Cas system. In all cases we detected 
eight cas genes most likely forming an operon. Then we 
compared the organization of this cas operon to others 
already characterized. Regarding the number of genes 
and their organization this was similar to that of the cas 
operon in E. coli K12, except for one gene (cse3) located 
in a different position [7]. This suggests that the CRISPR/
Cas system described here belong to the type I, subtype E 
group also known as CASS2 or Ecoli [7]. Included in this 
group are also the cas loci of G. vaginalis and S. enter-
ica. This particular CRISPR/Cas system type has been 
detected frequently in pathogenic bacteria (37%), and at 
least in most of the enterobacteria in which it has been 
sought [7, 13–15]. Given that in some bacteria CRISPR/
Cas systems are involved in virulence gene regulation, 
efforts to determine whether the CRISPR/Cas system 
in K. pneumoniae is involved in virulence should be 
conducted.
In regard with the CRISPR sequences, four out of the 
six systems detected in K. pneumoniae have two CRISPR 
arrays, one located upstream and one downstream of the 
cas operon. This contrasts with other CRISPR arrays in 
other bacteria, which usually have one located down-
stream of cas2 [13, 36, 37]. Duplication of CRISPR 
sequences in these systems might have a role in the 
mechanisms involved in the acquisition and transcrip-
tion of these arrays. The latter would have to be studied 
thoroughly and is a project that we are currently working 
on in our laboratory. Alternatively, the DR and spacers 
that are repeated in each CRISPR could be indicative of 
the “immune” memory of these bacteria. These findings 
highlight the importance of the research on CRISPR/Cas 
characterization in K. pneumoniae.
The length of the DR sequences of K. pneumoniae 
CRISPR arrays was 29–30 bp. In comparison, in S. Typhi 
these DR are 29 bp, in G. vaginalis, 28 bp and in C. jejuni, 
36  bp. This is consistent with reports in the literature 
that indicate that these DR sequences may have a size 
between 21 to 48 bp [4, 13, 36, 37]. Concerning the nucle-
otide sequence of the CRISPR region, in K. pneumoniae 
the DR sequences were the same in each CRISPR array 
of a single strain but different from strain to strain, simi-
lar to what has been observed in other CRISPR arrays. 
On the other hand, this contrasts with reported on S. 
Typhi IMSS CRISPR-1 which DR sequences are similar to 
those in S. Typhi CT18 and E. coli K12, as well as in C. 
jejuni strain UPTC CF89-12 whose consensus sequence 
has a 92–100% similarity with repeats from other 
Campylobacter strains. At this moment we cannot pre-
dict whether the DR in K. pneumoniae is evolutionarily 
related to those in E. coli or not.
Regarding the spacer sequences, these are incorporated 
into the CRISPR array and provide a historical view of 
the exposure of bacteria to a variety of external genetic 
elements [38]. Spacer sequences in K. pneumoniae have 
an average size of 33 bp, similar to those reported in G. 
vaginalis, C. jejuni, and S. Typhi. This is consistent with 
reports in the literature indicating that these spacers can 
have a size between 26 and 72 bp [4, 13, 36, 37].
In this study, 38 out of 116 CRISPR spacer sequences 
showed similarities with either phage, plasmids or bac-
terial genomes. This characteristic has been widely 
reported in other spacer sequences and is one of the 
bases for the interest in these systems [28]. In our study 
we were able to detect that some of these sequences were 
similar to more than one region of the same phage or 
plasmid sequence but from a different region. Findings 
such as these suggest that CRISPR interference prevents 
phage or common plasmid acquisition in these strains 
and those different regions are recognized and included 
as spacers [8].
Furthermore, it has also been reported that spacer 
sequences have no similarity to other sequences of for-
eign genetic material in a variety of bacteria such as S. 
Typhi, G. vaginalis and C. jejuni [13, 36, 37]. However, 
in this study, the proportion of sequences that did show 
similarity to others contained in the GenBank database 
was greater than in any previous reports. The concord-
ance of the detected spacer sequences was mainly with 
integrases, viral replication proteins or plasmids, gene 
sequences coding for viral structures, exonucleases, and 
hypothetical or non-described genes. Likewise, a similar-
ity to cas gene sequences or the Klebsiella genome itself 
was found; this fact suggests what in some studies has 
been proposed as autoimmunity. This means that marked 
CRISPR/Cas system sequences cause a partial or total 
degradation of their own activity. Another possibility is 
that the incorporation of this type of spacers occurs due 
to errors of the Cas proteins involved in this process [2]. 
However, the mechanisms that select the regions that 
will integrate the CRISPR remain unknown, but it is sug-
gested that they are not random events and that proto-
spacer adjacent motifs, also called PAM (a sequence 
located at the 3′ or 5′ end of the protospacer or the 
sequence present in the foreign genetic element), seem to 
determine the orientation of the spacer within the repeat 
array [4].
Conclusion
The search for and the description of this system in 
pathogenic bacteria could have countless implications, 
Page 8 of 10Ostria‑Hernández et al. BMC Res Notes  (2015) 8:332 
ranging from success in new therapeutic procedures, 
typing methods or determining the evolutionary role of 
these microorganisms to finally understanding the rea-
sons why this system has been lost or shut down and 
the implications that this could have on the emergence 
of highly virulent pathogens. In K. pneumoniae, the 
CRISPR/Cas system was not homogeneously distrib-
uted; however, detection in some strains opens the pos-
sibility to diverse hypotheses about its functionality and 
regulatory mechanisms. It is necessary to demonstrate 
that strains that contain it, keep it functional, as well as 
to determine the relationship between its presence and 
extrinsic environmental factors or regulatory mecha-
nisms involved in its expression. Thus, understanding the 
role of this system could provide information about the 
evolutionary history of this and other pathogens.
Methods
Searching for the CRISPR/Cas in K. pneumoniae
The complete genomes of eight K. pneumoniae con-
tained in the CRISPRdb database were analyzed with the 
CRISPRFinder platform available at http://crispr.u-psud.
fr [20]. This algorithm locates direct repeat sequences 
of 23–55  bp separated by variable sequences of a size 
no greater than 2.5 times or no less than 0.6 times the 
length of the repeated sequences (25–60 bp). When the 
algorithm detects at least three repeating regions that 
are exactly the same (in sequence and size), which are 
separated by variable sequences, it is considered a “con-
firmed CRISPR”. If the algorithm locates two repeats sep-
arated by a variable sequence, it establishes the status of 
a “questionable CRISPR”. For the present study we only 
considered those indicated by the program as “confirmed 
CRISPRs”. In addition, with this platform, we searched 
for cas genes in regions adjacent to CRISPR sequences.
In order to search for the CRISPR/Cas system in 
draft genomes we downloaded 44 K. pneumoniae draft 
genome sequences from the NCBI database in ftp://ftp.
ncbi.nlm.nih.gov/genomes/Bacteria_DRAFT to build a 
local database using Standalone BLAST (BLASTn and 
BLASTp). Given that cas1 is considered a genetic and 
universal marker for the CRISPR/Cas systems we used 
the sequences of cas1 and the Cas1 protein from K. pneu-
moniae strain 1084 to perform the BLAST searches as 
described above. Expectation values (e-value) less than or 
equal to 0.0001 for cas1 and 0.001 for the protein were 
considered significant as well as a coverage percentage of 
more than or equal to 80%. As a control we also analyzed 
the sequences of all eight complete genomes expecting 
the same results as those shown in the CRISPRFinder 
database. Fragments containing cas1 and Cas1 were 
selected, uploaded and analyzed with CRISPRFinder 
using the same parameter as with the complete genomes. 
To corroborate the CRISPRFinder results we generated 
five 20 kbp random sequences derived from the genome 
of strain 1084 using RSAT [39] and analyzed them using 
the CRISPRFinder platform. Our results showed that no 
CRISPR sequences were found in any of the sequences 
analyzed.
CRISPR/Cas genomic context
The BioCyc platform, http://biocyc.org [40], was used 
to visualize the genomic context of the cas operon in 
complete genomes. Subsequently, the same analysis was 
performed with draft genomes containing cas1 using 
CRISPRFinder and using the information contained in 
GenBank. Progressive alignment was performed with 
MAUVE using the default parameters set by the pro-
gram, to determine the similarity and synteny in the 
regions obtained [41].
Analysis of spacers and direct repeats (DRs)
Once the genomes with a CRISPR sequences were ana-
lyzed with the CRISPRFinder platform the detected 
spacer and repeat sequences were obtained as output 
files. Each spacer sequence was compared to genome 
sequences of viruses (taxid: 10239) and Bacteria (taxid: 
2) available at the NCBI database using nucleotide 
BLAST and the BLASTn algorithm. The criteria used 
to determine significant similarity were e-values less 
than or equal to 0.0001 and a score greater than 40. All 
spacer sequences were aligned with the parameters set 
by the MAFFT program [42] to determine whether or 
not a CRISPR sequence is shared with other CRISPR 
sequences (service available at: http://www.ebi.ac.uk/
Tools/msa/mafft/).
Furthermore, the consensus sequences of the DR from 
each CRISPR were also obtained from CRISPRFinder and 
aligned with ClustalX2 [43] and MUSCLE [44]. Subse-
quently, these were analyzed with the WebLogo software 
[45] to establish nucleotides that are conserved among all 
sequences.
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